6-29588982-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_007160.4(OR2H2):c.*99C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0626 in 649,122 control chromosomes in the GnomAD database, including 1,691 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.050 ( 249 hom., cov: 32)
Exomes 𝑓: 0.067 ( 1442 hom. )
Consequence
OR2H2
NM_007160.4 3_prime_UTR
NM_007160.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.17
Publications
19 publications found
Genes affected
OR2H2 (HGNC:8253): (olfactory receptor family 2 subfamily H member 2) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
GABBR1 (HGNC:4070): (gamma-aminobutyric acid type B receptor subunit 1) This gene encodes a receptor for gamma-aminobutyric acid (GABA), which is the main inhibitory neurotransmitter in the mammalian central nervous system. This receptor functions as a heterodimer with GABA(B) receptor 2. Defects in this gene may underlie brain disorders such as schizophrenia and epilepsy. Alternative splicing generates multiple transcript variants, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jan 2016]
GABBR1 Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with language delay and variable cognitive abnormalitiesInheritance: AD Classification: MODERATE Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OR2H2 | NM_007160.4 | c.*99C>T | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000641840.1 | NP_009091.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| OR2H2 | ENST00000641840.1 | c.*99C>T | 3_prime_UTR_variant | Exon 2 of 2 | NM_007160.4 | ENSP00000492959.1 | ||||
| GABBR1 | ENST00000355973.7 | c.*2+14559G>A | intron_variant | Intron 18 of 18 | 2 | ENSP00000348248.3 | ||||
| OR2H2 | ENST00000383640.4 | c.*99C>T | downstream_gene_variant | 6 | ENSP00000373136.2 |
Frequencies
GnomAD3 genomes AF: 0.0498 AC: 7584AN: 152150Hom.: 251 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
7584
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0665 AC: 33045AN: 496854Hom.: 1442 Cov.: 0 AF XY: 0.0710 AC XY: 18738AN XY: 263804 show subpopulations
GnomAD4 exome
AF:
AC:
33045
AN:
496854
Hom.:
Cov.:
0
AF XY:
AC XY:
18738
AN XY:
263804
show subpopulations
African (AFR)
AF:
AC:
297
AN:
13762
American (AMR)
AF:
AC:
1617
AN:
23770
Ashkenazi Jewish (ASJ)
AF:
AC:
1272
AN:
14766
East Asian (EAS)
AF:
AC:
2413
AN:
32316
South Asian (SAS)
AF:
AC:
6746
AN:
49270
European-Finnish (FIN)
AF:
AC:
1173
AN:
45354
Middle Eastern (MID)
AF:
AC:
405
AN:
3686
European-Non Finnish (NFE)
AF:
AC:
17195
AN:
286178
Other (OTH)
AF:
AC:
1927
AN:
27752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1834
3668
5501
7335
9169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0498 AC: 7582AN: 152268Hom.: 249 Cov.: 32 AF XY: 0.0506 AC XY: 3765AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
7582
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
3765
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
894
AN:
41550
American (AMR)
AF:
AC:
814
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
292
AN:
3470
East Asian (EAS)
AF:
AC:
509
AN:
5182
South Asian (SAS)
AF:
AC:
638
AN:
4828
European-Finnish (FIN)
AF:
AC:
298
AN:
10606
Middle Eastern (MID)
AF:
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3953
AN:
68020
Other (OTH)
AF:
AC:
130
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
371
742
1113
1484
1855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
327
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.